Skip to content
OpenCapital
Get started

Profound Medical PROF Cash ratio

Cash ratio at other companies

Intuitive Surgical logo
Intuitive SurgicalISRG
1.1×-0.6×
Bioventus logo
BioventusBVS
0.2×+0.1×
Globus Medical logo
Globus MedicalGMED
1.2×0.0×

Other financials

Income statement

See full
Revenue$5.3M+104%
Gross profit$3.8M+107%
Operating income-$8.0M+28.2%
Net income-$7.1M+34.2%
EPS (diluted)$0.19-47.2%

Balance sheet

See full
Cash & equivalents$50.3M+8.3%
Total debt$7.5M+52.8%
Total equity$59.4M+17.0%
Total assets$73.5M+20.7%

Cash flow

See full
Operating cash flow-$8.6M-3.6%
CapEx$44.0K—
Free cash flow-$9.6M—

Valuation

See full
Market cap$241.65M+30.7%
Enterprise value$198.81M+28.7%
P/S12.8×-2.8×

Profitability

See full
Gross margin71.1%+3.4pp
Operating margin-202.6%-51.3pp
Net margin-206.8%-39.0pp
FCF margin-238.4%—

Returns & leverage

See full
Return on equity-70.6%+4.8pp
Debt / equity0.1×0.0×
Current ratio6.6×-4.8×

Where this comes from

Calculated from Profound Medical’s reported figures.

cash and equivalents/total current liabilities=4.7×

Based on the most recent quarter.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Profound Medical's cash ratio?
Profound Medical (PROF) reported cash ratio of 4.7× in Q1 2026.
How has Profound Medical's cash ratio changed year-over-year?
Profound Medical's cash ratio decreased by 45.9% year-over-year, from 8.8× to 4.7×.
What is the long-term trend for Profound Medical's cash ratio?
Over 2 years (2023 to 2025), Profound Medical's cash ratio has grown at a 54.5% compound annual growth rate (CAGR), from 4.1× to 9.8×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.